Scilex Holding Company

NASDAQ:SCLX   3:59:57 PM EDT
4.06
+0.06 (+1.37%)
5:43:38 PM EDT: $4.26 +0.20 (+4.93%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Scilex Holding Company Stock, NASDAQ:SCLX

960 San Antonio Road, 1 Habourfront Avenue, Palo Alto, California 94303
United States of America
Phone: +1.650.516.4310
Number of Employees:

Description

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.